The U.S. Food and Drug Administration has issued an alert for “a potentially high-risk issue” regarding two glucose monitor sensors that have been malfunctioning, leading to multiple fatalities.

The federal agency shared a message on its website stating that it has been made aware of two Abbott Diabetes Care sensors providing “incorrect low glucose readings.” In the recent alert, the FDA said Abbott “reported 736 serious injuries, and seven deaths associated with this issue” as of Nov. 14.

Abbott previously notified customers that certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors sold by the healthcare company had a manufacturing issue, as announced in a press release on Nov. 24.

Courtesy Abbott

The company confirmed that more than 3 million FreeStyle Libre 3 and FreeSty

See Full Page